Prognostic impact of <i>EGFR</i> and <i>KRAS</i> mutations in lung cancer survival during pre-tki era: the real scenario at a cancer public center of reference in Brazil
Objective: To evaluate the genetic tests is fundamental for the adequate treatment of non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors (TKI). Given that access to this evaluation is still limited for those who depend on the Brazilian Public Health System, it seems import...
Saved in:
| Main Authors: | Thais Abreu Almeida, Jeanine Marie Nardin, Amanda Jurgensen, Janaina Takahashi, Juliana Jung, Graziele Losso, José C. Casali-da-Rocha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações Ltda.
2019-01-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.5935/2526-8732.20190004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of osimertinib in advanced T790M-positive NSCLC after progression to prior EGFR-TKI: real world data from a Brazilian cohort
by: Luiz Henrique Araujo, et al.
Published: (2020-01-01) -
Central nervous system metastases of lung adenocarcinoma harboring EGFR-activating mutations: survival results from a multidisciplinary approach, including EGFR-TKIs
by: Guilherme Harada, et al.
Published: (2020-01-01) -
Genetic variants related to angiogenesis and apoptosis in patients with glioma
by: Maria Clara Jessica Calastri, et al. -
Biotecnología para el estudio de enfermedades neuropsiquiátricas y la búsqueda de nuevos tratamientos: caso de las neuregulinas
by: María Clara Soto-Bernardini
Published: (2019-09-01) -
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC
by: Lee AT, et al.
Published: (2024-12-01)